EDGAR Filing Documents for 0001600132-17-000044

Form 424B5 - Prospectus [Rule 424(b)(5)]:

SEC Accession No. 0001600132-17-000044

Filing Date

2017-05-11

Accepted

2017-05-11 06:55:21

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B5	prospectussupplementmay2017.htm	424B5	480795
2		blphlogoa15.jpg	GRAPHIC	32979
3		inopulseproducta09.jpg	GRAPHIC	27238
4		inopulseproducta10.jpg	GRAPHIC	27238
	Complete submission text file	0001600132-17-000044.txt		602642

Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059

Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770

Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-211166 | Film No.: 17832474
SIC: 2834 Pharmaceutical Preparations